Literature DB >> 6884310

Prognosis in equine colic: a comparative study of variables used to assess individual cases.

B W Parry, G A Anderson, C C Gay.   

Abstract

The present retrospective study compared objectively the prognostic value of many variables routinely used in the assessment of equine colic cases. The best prognostic variables were those which assessed the integrity of cardiovascular function. Ranked in order of decreasing merit the following variables were able to discriminate between horses which lived and those which died: systolic pressure, blood lactate concentration, oral mucous membrane capillary refill time, diastolic pressure, arterial pulse amplitude, degree of mental depression, blood urea concentration, haematocrit, heart rate, haematocrit/plasma protein ratio, oral mucous membrane colour, jugular filling rate, frequency of gut sounds, differential blood leucocyte count, blood glucose concentration and respiratory rate. Assessment of systolic pressure alone appropriately classified the outcome (survival or death) of 86 per cent (64 out of 73) cases examined. Combined assessment of systolic pressure, blood lactate concentration, blood urea concentration and haematocrit permitted accurate classification of 93 per cent (68 of 73) of the cases examined. Outcome classification formulae for these four variables, alone and in all combinations, are presented.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6884310     DOI: 10.1111/j.2042-3306.1983.tb01768.x

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  11 in total

1.  Clinical findings, diagnoses, and outcomes of horses presented for colic to a referral hospital in Atlantic Canada (2000-2015).

Authors:  Jaclyn M Kaufman; Omid Nekouei; Aimie J Doyle; Nora M Biermann
Journal:  Can Vet J       Date:  2020-03       Impact factor: 1.008

2.  A computer-derived protocol using recursive partitioning to aid in estimating prognosis of horses with abdominal pain in referral hospitals.

Authors:  P J Pascoe; N G Ducharme; G R Ducharme; J H Lumsden
Journal:  Can J Vet Res       Date:  1990-06       Impact factor: 1.310

3.  Prognosis in equine colic patients using multivariable analysis.

Authors:  M J Reeves; C R Curtis; M D Salman; B J Hilbert
Journal:  Can J Vet Res       Date:  1989-01       Impact factor: 1.310

4.  A retrospective study of 51 cases of abdominal problems in the calf: etiology, diagnosis and prognosis.

Authors:  J M Naylor; J V Bailey
Journal:  Can Vet J       Date:  1987-10       Impact factor: 1.008

5.  Prognostic features and clinical presentation of acute idiopathic enterocolitis in horses.

Authors:  H R Staempfli; H G Townsend; J F Prescott
Journal:  Can Vet J       Date:  1991-04       Impact factor: 1.008

6.  D-dimer improves the prognostic value of combined clinical and laboratory data in equine gastrointestinal colic.

Authors:  M Sandholm; A Vidovic; A Puotunen-Reinert; S Sankari; K Nyholm; H Rita
Journal:  Acta Vet Scand       Date:  1995       Impact factor: 1.695

7.  Prospective survey of veterinary practitioners' primary assessment of equine colic: clinical features, diagnoses, and treatment of 120 cases of large colon impaction.

Authors:  Kyra Jennings; Laila Curtis; John Burford; Sarah Freeman
Journal:  BMC Vet Res       Date:  2014-07-07       Impact factor: 2.741

8.  Effect of Dexamethasone on Resting Blood Lactate Concentrations in Horses.

Authors:  K Mizen; J Woodman; S R Boysen; C Wagg; P Greco-Otto; R Léguillette; M-F Roy
Journal:  J Vet Intern Med       Date:  2016-12-25       Impact factor: 3.333

9.  Metabolism during anaesthesia and recovery in colic and healthy horses: a microdialysis study.

Authors:  Anna H Edner; Birgitta Essén-Gustavsson; Görel C Nyman
Journal:  Acta Vet Scand       Date:  2009-03-10       Impact factor: 1.695

10.  Metabolism before, during and after anaesthesia in colic and healthy horses.

Authors:  Anna H Edner; Görel C Nyman; Birgitta Essén-Gustavsson
Journal:  Acta Vet Scand       Date:  2007-11-15       Impact factor: 1.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.